摘要：投稿信（Cover Letter）是论文与期刊编辑的第一次正式对话，其核心目标是让编辑在30秒内快速理解研究的价值，并产生“值得送审”的判断。今天我将结合最新投稿实践，为大家提供可直接套用的模板与避坑指南。
投稿信（Cover Letter）是论文与期刊编辑的第一次正式对话，其核心目标是让编辑在30秒内快速理解研究的价值，并产生“值得送审”的判断。今天我将结合最新投稿实践，为大家提供可直接套用的模板与避坑指南。
优先使用期刊官网显示的编辑姓名（如“Dear Dr. Smith”），若未知则用“Dear Editors of [Journal Name]”。
研究价值的三段式表达背景痛点：用1句话说明领域空白（例：“Existing studies on X fail to address Y in Z context.”）。
核心发现：用数据或机制描述创新点（例：“We demonstrate that A increases B by 40% via C pathway.”）。
期刊契合性：关联期刊近期论文（例：“This aligns with your 2024 paper on D, which highlighted E.”）。
道德声明与作者权限必须包含三重声明：
“This manuscript is original and not under consideration elsewhere.”
“All authors have approved the submission.”
“No conflicts of interest exist.”
若涉及伦理审批，需补充“Approved by [Institution] Ethics Committee (Protocol #XXX)”。
[Your Institution]
[Date]
Dear Dr. [Editor’s Last Name],
We are pleased to submit our manuscript entitled “Title: Novel Mechanism of X in Y Disease” for consideration in [Journal Name].
Background & Innovation:
Current therapies for Y disease lack specificity (1). Our study reveals that X protein directly inhibits Z enzyme, reducing disease progression by 58% in mouse models (2). This mechanism challenges the prevailing view that X only acts via A pathway (3).
Methodology & Findings:
Using CRISPR knockout and single-cell RNA-seq, we identified 3 key genes mediating X’s effect. Notably, gene B’s role was previously unknown in this context (4).
Journal Relevance:
Your 2024 review on Z enzyme modulation (5) and our finding that X targets this enzyme suggest strong interest among your readers.
Ethics & Approvals:
All experiments complied with ARRIVE guidelines and were approved by [Institution] IACUC (#2024-001).
We recommend Dr. Jane Doe (Univ. of X, expertise in Z enzyme) and Dr. John Smith (Y Disease Foundation, clinical trial design) as reviewers.
Thank you for considering our work. Please contact me at [Email] or [Phone] for any clarifications.
Sincerely,
[Your Full Name]
[Your Title]
[Institution]
1. 避免“自嗨式”表述
❌ 错误：“Our study is groundbreaking.”
✅ 正确：“This is the first report of X in human Y tissue.”
2. 控制篇幅与格式
总字数≤500词，段落≤5句，字体Times New Roman 12pt，行距1.15。
3. 避免使用表格、公式或参考文献（若需引用，用“(1)”标注并在文末列出）。
4. 避免在邮件正文重复粘贴全文，仅需写“Manuscript and Cover Letter attached.”
写在最后：在AI生成工具普及的今天，Cover Letter的个性化表达反而成为稀缺价值。建议作者在提交前，用30秒口述研究亮点并录音，再将其转化为文字——这种“口语化提炼”往往比刻意雕琢的语句更具感染力。毕竟，真正打动编辑的，永远是研究本身的光芒，而非信件的辞藻。
意得辑为您提供一站式SCI论文服务，从润色到翻译再到发表支持，是学术研究者信赖的专业选择。如果您需要关于SCI论文投稿指导与协助，欢迎访问意得辑官方网站，我们将为您提供更多详细信息和专业建议。
来源：我是冉崇云